Affiliation:
1. LECOM: Lake Erie College of Osteopathic Medicine
2. St. John Riverside Hospital
3. St. John's Riverside Hospital
Abstract
Abstract
Acute pancreatitis is the leading cause of gastrointestinal hospital admissions in the United States [1]. While there are variety of presentations, the majority to not require stay in the intensive care unit. Medication side effect is one large cause of pancreatitis. More recently diabetic agents have been linked to pancreatitis. Here we describe a case of pancreatitis caused by a SGLT-2 Inhibitor, Empagliflozin, and the acceleration into hyperosmolar hypoglycemic syndrome and ICU admission. We hope to provide more information for clinicians detailing the link and outlining the management in cases such as this which do significantly increase inpatient morbidity and mortality.
Publisher
Research Square Platform LLC
Reference8 articles.
1. (n.d.).;Vege SS;UpToDate Retrieved February,2023
2. Nationwide Trends in Acute and Chronic Pancreatitis Among Privately Insured Children and Non-Elderly Adults in the United States, 2007–2014;Sellers ZM;Gastroenterology,2018
3. Critical care management of severe acute pancreatitis;Tesoriero R,2016
4. Drug-induced acute pancreatitis: a review;Jones MR;Ochsner J
5. Risks vs Benefits for SGLT2 Inhibitor Medications;Pittampalli S;Fed Pract,2018